bpc 157 starter dose BPC-157 Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Bottle Size:100 mL LY3298176 5-Amino-1MQ - 5mg &

bpc 157 starter dose BPC-157 Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Bottle Size:100 mL LY3298176 5-Amino-1MQ - 5mg &

5-Amino-1MQ - 5mg & 50mg - 5mg

Rome: world Health Organization, Food and Agriculture Organization of the United Nations

LY3298176

Bottle Size:100 mL

My clinical assessment: For tendinopathies and degenerative joint problems , PRP aligns better with the goals of biologic repair and durable improvement , without exposing patients—especially those with diabetes—to steroid-related systemic risks